administration options 1,2 important administration instructions 1 See the Instructions for Use for more detailed instructions on the preparation and administration of DUPIXENT Patients and/or caregivers should read the Instructions for Use prior to injecting Instruct patients and/or caregivers to administer the subcutaneous injection into the thigh or abdomen, except for the 2 inches (5 cm) around the navel The upper arm can also be used if a caregiver administers the injection It is important to rotate the injection site with each injection
Both semaglutide and tirzepatide have not been studied extensively in pregnant women, but animal studies suggest potential risks to fetal development, including: Fetal growth restriction Structural abnormalities Miscarriage (observed in animal studies at high doses) Stillbirth, animal studies show risk at all doses
These studies revealed that the absence of the gut microbiota leads to alterations in stress responses, neurotransmitter levels, and neurodevelopment [3, 4]
Treating only one pathway usually produces partial improvement, not reliable clearance
BIBLIOGRAPHY (1) Estato, V., Obadia, N., Chateaubriand, P.H